Humana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024.
- Revenue
- +26.1%
- EPS
- −16.7%
- Free cash flow
- +158.7%
- Total debt
- −0.82%
Quarter to September 2026, against a year earlier
Follow HUM
Alert me
Humana Inc. (HUM) P/E ratio
As of 6 November 2026, Humana Inc. (HUM) trades at a P/E ratio of 41.9×. Over the past ten years it has ranged from 10.6× (March 2020) to 55.1× (March 2017); the current reading is higher than 98% of that period. That is above the Healthcare Plans industry median of 22.5× and above the Healthcare sector median of 24.5×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 26.0× | 2.49% |
| FY2024 | 25.4× | 7.67% |
| FY2023 | 23.6× | 4.39% |
| FY2022 | 22.6× | 11.01% |
| FY2021 | 20.4× | 26.31% |
| FY2020 | 16.1× | (11.28%) |
| FY2019 | 18.2× | (22.40%) |
| FY2018 | 23.4× | 56.16% |
| FY2017 | 15.0× | (69.81%) |
| FY2016 | 49.7× | 137.25% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 36.8× | (1.44%) |
| Jun 2026 | 37.3× | 101.99% |
| Mar 2026 | 18.5× | (29.06%) |
| Dec 2025 | 26.0× | 6.95% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MOH Molina Healthcare, Inc compare | n/m |
| CVS CVS Health Corporation compare | 9.6× |
| OSCR Oscar Health, Inc. compare | 11.0× |
| CI Cigna Group compare | 12.9× |
| ELV Elevance Health, Inc. compare | 18.2× |
| UNH UnitedHealth Group Incorporated compare | 22.5× |
| CNC Centene Corporation compare | 23.5× |
| PGNY Progyny, Inc. compare | 30.1× |
| HUM Humana Inc. | 41.9× |
| Healthcare Plans industry median | 22.5× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on HUM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement